Acute Pain Clinical Trial
Official title:
Post-operative Electroacupuncture as Part of the Multimodal Analgesic Regimen for Laparoscopic or Robotic Colorectal Surgery
A multimodal approach for management of post-operative pain is used to improve analgesia,
minimize side effects, and improve recovery. Nevertheless, opioid analgesics and intravenous
patient controlled analgesia remains the mainstay of postoperative analgesia after colorectal
surgery. Opioids are associated with various side effects such as nausea, vomiting, sedation,
dizziness, respiratory depression, urinary retention and reduced bowel movement. These side
effects are unpleasant and lead to prolonged recovery.
Use of non-pharmacological analgesic techniques may improve postoperative pain control and
reduce opioid consumption. Acupuncture has been used for over 3000 years in China for
treatment of pain and various other conditions. Acupuncture and related techniques are simple
and safe. There is evidence that acupuncture can reduce postoperative pain intensity, opioid
consumption, and opioid related side effects.
Procedures Patients will be approached at the pre admission clinic or in the general ward
before the operation. The analgesic modalities will be explained and the patient will be
recruited into the study if s/he agrees. The patient will subsequently be randomized into one
of two groups. Patients in the first group (M) will receive intraoperative morphine, local
wound infiltration with local anaesthetic, paracetamol, cyclooxygenase-2 (COX-2) inhibitor
and postoperative patient controlled analgesic (PCA) morphine. Patients in the second group
(E) will receive postoperative electroacupuncture in addition to intraoperative morphine,
local wound infiltration with local anaesthetic, COX-2 inhibitor, paracetamol and
postoperative PCA morphine.
Randomization and blinding Patients recruited for laparoscopic colonic and rectal surgery
will be stratified in randomization. To ensure all groups have equal sample size, each
randomization will be based on using 10 blocks of 10 patients for each type of operation
(colonic and rectal). A computer generated random sequence will be used to select the
allocation order.
This is a single blinded randomized control trial. Blinding will not be done for the
patients. The investigator assessing the patients for data collection after the operation
will be blinded.
Analgesic modalities and pain assessment Group E In addition to the standard protocol applied
to patients in group M, patients in the electroacupuncture group (E) will receive 4 sessions
of electroacupuncture after surgery over four days, with each session lasting 30 minutes. The
first session will start 3 hours after surgery on post op day 0. Subsequently, patients will
receive 1 sessions each morning on post op days 1, 2, and 3. The acupoints that will be
stimulated are: daheng, tianshu, zhongwan, xiawan, qihai, guanyuan, hegu, quchi, zusanli,
sanyinjiao, gongsun. An alternating fast-slow frequency of 20Hz/6Hz will be used with an
interval of 250msec. The intensity (mA) will be adjusted to a level tolerated by each
individual patient. Electroacupuncture will be performed by qualified acupuncturists from the
School of Chinese Medicine, The University of Hong Kong.
Group M Patients in group M will receive intravenous morphine, paracetamol, COX-2 inhibitor,
local wound infiltration with local anaesthetic and post operative PCA morphine only as
mentioned above. Neither electroacupuncture nor sham acupuncture will be given.
Postoperative care and assessment Early mobilization is encouraged after operation. Patients
will be put on fluid diet on postoperative day 0.
Postoperative assessments such as gastrointestinal function (bowel sound, flatus, bowel
opening), occurrences of postoperative complications, and suitability for discharge (good
pain control, ambulation, normal bowel function, ability to eat properly without vomiting or
abdominal distention) would be performed by the surgical team.
Pain control using the numerical rating scale (NRS) scale from 0-10 and patient satisfaction
with analgesia will be assessed upon discharge.
Blood sampling In order to determine the plasma concentrations of adenosine, encephalin,
beta-endorphin, dynorphin and alpha-endomorphin, and methylation status and gene expression
of mu-, delta- and kappa-opioid receptors, 10 mls of blood will be drawn (4 mls into
Ethylenediaminetetraacetic acid (EDTA) and 6 mls into heparinised blood collection tubes) at
the following time-points in all subjects: Prior to first acupuncture session, prior to
second acupuncture session, prior to 4th acupuncture session and prior to 6th acupuncture
session.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT03825549 -
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
|
N/A | |
Completed |
NCT05995912 -
Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain
|
Phase 2 | |
Recruiting |
NCT05589246 -
Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure
|
N/A | |
Recruiting |
NCT05572190 -
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
|
Phase 1 | |
Terminated |
NCT04716413 -
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
|
Phase 4 | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Not yet recruiting |
NCT06317844 -
Examination of Psychological and Physiological Pathways Linking Gratitude and Pain
|
N/A | |
Withdrawn |
NCT02957097 -
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
|
Phase 4 | |
Terminated |
NCT02599870 -
Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures
|
N/A | |
Completed |
NCT02565342 -
Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery
|
Phase 4 | |
Completed |
NCT02380989 -
Integrative Ayurveda Healing Relieves Minor Sports Injury Pain
|
Phase 2 | |
Completed |
NCT02984098 -
40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose
|
Phase 4 | |
Completed |
NCT02489630 -
Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department
|
Phase 4 | |
Completed |
NCT03107338 -
Preventive Treatment of Pain After Dental Implant Surgery
|
Phase 4 | |
Completed |
NCT02817477 -
Intranasal Ketamine for Acute Traumatic Pain
|
Phase 4 |